wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28247667-8032BD23-2EA8-4136-B3C6-04235E2341BE
Q28247667-8032BD23-2EA8-4136-B3C6-04235E2341BE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28247667-8032BD23-2EA8-4136-B3C6-04235E2341BE
Favourable outcomes of (177)Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours
P2860
Q28247667-8032BD23-2EA8-4136-B3C6-04235E2341BE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28247667-8032BD23-2EA8-4136-B3C6-04235E2341BE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8f169e3905d0785bce4a1b57e18161397722d346
P2860
177Lu-octreotate, alone or with radiosensitising chemotherapy, is safe in neuroendocrine tumour patients previously treated with high-activity 111In-octreotide.